Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Navigen Announces FDA Clearance of IND Application to Initiate First-in-Human Studies for CPT31

americanpharmaceuticalreviewDecember 16, 2019

Tag: Navigen , FDA , IND , CPT31

PharmaSources Customer Service